tert-Butyl 3-[(1E)-3-ethoxy-3-oxoprop-1-en-1-yl]azetidine-1-carboxylate

Catalog No. :
ACDTWL658
CAS No. :
193085-21-1
Molecular Formula :
C13H21NO4
Molecular Weight :
255.31

IUPAC Name:tert-butyl (E)-3-(3-ethoxy-3-oxoprop-1-en-1-yl)azetidine-1-carboxylate

tert-Butyl 3-[(1E)-3-ethoxy-3-oxoprop-1-en-1-yl]azetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$539.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-[(1E)-3-ethoxy-3-oxoprop-1-en-1-yl]azetidine-1-carboxylate
IUPAC Nametert-butyl (E)-3-(3-ethoxy-3-oxoprop-1-en-1-yl)azetidine-1-carboxylate
MDL No.MFCD17012828
Molecular FormulaC13H21NO4
Molecular Weight255.31
SMILESO=C(N1CC(/C=C/C(OCC)=O)C1)OC(C)(C)C
InChI KeyMCCBAJUVDBBRKP-VOTSOKGWSA-N
Synonym(Z)-tert-butyl 3-(3-ethoxy-3-oxoprop-1-en-1-yl)azetidine-1-carboxylate;1-Azetidinecarboxylic acid, 3-[(1E)-3-ethoxy-3-oxo-1-propen-1-yl]-, 1,1-dimethylethyl ester;(E)-tert-Butyl 3-(3-ethoxy-3-oxoprop-1-en-1-yl)azetidine-1-carboxylate;3-(2-Ethoxycarbonyl-vinyl)-azetidine-1-carboxylic acid tert-butyl ester;tert-butyl 3-(1E)-3-ethoxy-3-oxoprop-1-en-1-ylazetidine-1-carboxylate
CAS No.193085-21-1

Synthetic Route by SureRoute

1. ACDTWL658 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRDZ250 route compound structure diagram
    ACLRDZ250177947-96-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDTWL658 route product structure diagram
    ACDTWL658193085-21-1
Inquiry

2. ACDTWL658 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLRDZ250 route compound structure diagram
    ACLRDZ250177947-96-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDTWL658 route product structure diagram
    ACDTWL658193085-21-1
Inquiry

Comments (0)